- Home
- UBXG vs TLPH Comparison
UBXG vs TLPH Comparison
Compare UBXG & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBXG | TLPH |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.0M | 64.7M |
| IPO Year | 2024 | 2011 |
Fundamental Metrics
Financial Performance| Metric | UBXG | TLPH |
|---|---|---|
| Price | $2.09 | $1.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 17.5K | ★ 365.3K |
| Earning Date | 12-22-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $29,674,534.00 | $28,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14,267.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.62 | $0.38 |
| 52 Week High | $4.64 | $1.57 |
Technical Indicators
Market Signals| Indicator | UBXG | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 36.10 |
| Support Level | $1.93 | $1.20 |
| Resistance Level | $2.09 | $1.25 |
| Average True Range (ATR) | 0.15 | 0.09 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 16.22 | 1.69 |
Price Performance
Historical ComparisonAbout UBXG U-BX Technology Ltd. Ordinary Shares
U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers. Its main offerings include three services/products: digital promotion services, risk assessment services, and value-added bundled benefits. The PRC operating entities help their institutional clients gain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or clients' promotion time on these channels. U-BX Beijing developed a unique algorithm named the Magic Mirror. The majority of revenue comes from digital promotion services. Geographically, all of the company's revenue is derived from Mainland China.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.